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exploring job satisfaction and factors contributing to job satisfac-
tion specific to pediatric SCT.
Results:
Of the participants, 90% of the respondents categorized them-
selves as APSCTN, some with additional responsibilities including
research and education and 85% are employed full time. 75% of
the respondents provide direct patient care with additional duties
in other areas.
Employing a Lickert-type scale from 1-10, 1 being very unsatis-
fied/very burnt out, 10 being very satisfied/not burnt out, 50% of
APSCTN categorized themselves as a 7 or greater with overall job
satisfaction. When characterizing current job burn out, 60% re-
sponded between 1-6, however when describing burnout about
nursing as a profession, 80% responded as a 7 or greater (Table 1).
Job satisfaction was associated with direct patient/family interac-
tion, clinical care, and satisfying relationships with MD’s and
medical staff. Conflict with hospital administration, understaffing
and difficulties with other hospital departments are cited as having
negative impact on job satisfaction.
Conclusions:
Job satisfaction remains high in the SCT discipline despite dif-
ficult interactions with hospital departments, administration and
chronic understaffing. However, nursing burnout remains a signif-
icant concern in pediatric SCT and should be addressed in this
unique group of professionals.
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Scale 1-10; 1 Very Unsatisfied/Very Burnt Out, 10 Very Satisfied/
Not Burnt out (n20)
<3 4-6 7-9 10
Job Satisfaction 2/20 8/20 10/20 0/20
Burnout in Current Job 4/20 8/20 6/20 2/20
Burnout Nursing as a Profession 1/20 3/20 9/20 7/20
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FASCIITIS AS A MANIFESTATION OF CHRONIC GRAFT VERSUS HOST
DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL
TRANSPLANTATION IN CHILDREN AND ADOLESCENTS: A SINGLE IN-
STITUTION EXPERIENCE
Duncan, C.N.1,2, Myers, K.L.1,2, Lehmann, L.E.1,2 1Dana Farber
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Chronic graft versus host disease (CGVHD) remains one of
the most challenging obstacles to successful outcome following
allogeneic hematopoietic stem cell transplantation (HSCT). Al-
though the incidence of CGVHD is less in children than in
adults the impact is devastating as both disease and therapy can
profoundly impact growth, development and functional out-
come. Fasciitis is a rare manifestation of CGVHD that can
occur without other organ involvement. Histologically edema
and fibrosis are present in the septae separating subcutaneous fat
lobules and in the muscular fascia beneath; overlying epidermis
is unaffected. Patients present with painful edema that almost
always progresses to fascial scarring. Ultimately the process
leads to loss of tissue flexibility and a dimpled “peu d’orange “
appearance of the skin associated with poor functional and
cosmetic outcome. From January 1999 through December 2005
we performed 305 allogeneic HSCT; 5 patients received donor
lymphocyte infusions (DLI) during this time.40 had significant
CGVHD, 9 post- related SCT, 31 post-unrelated donor SCT
and one following DLI. Of these patients 8 have been diagnosed
with significant fasciitic CGVHD, 1 after a 3rd DLI, 3 after
related donor SCT (2nd SCT for one)and 4 following matched
unrelated donor(UD) SCT. 2 patients received peripheral blood
stem cells as the donor source; the remaining 5 received bone
marrow.3 had acute or chronic leukemias and 1 had an immu-
nodeficiency. The children ranged from 4-17 years of age at the
time of diagnosis and the diagnosis occurred 7 mos to 2 yrs after
HSCT/DLI. All patients had oral GVHD at diagnosis; 7/8 had
no other CGVHD. Excluding the patient developing fasciitis
post-DLI, all failed to respond to steroid therapy including
doses of up to 3mg/kg/day. Currently one child has died of
infection with aspergillus and atypical mycobacterium, 2 are off
all immunosuppression with resolution of disease after therapy
with MMF and steroids, 2 have disease control on weaning
immunosuppression including MMF and 3 have active disease
that impacts mobility despite multiagent therapy. No patient
with leukemia has had disease recurrence. Fasciitis can occur
with minimal other manifestations of CGVHD and inital find-
ings such as painful edema or fascial thickening may be subtle.
Steroid therapy may prove ineffective illuminating the necessity
for other therapeutic agents as significant functional limitations
occur if the disease can not be controlled.
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SEVERE VENO-OCCLUSIVE DISEASE AFTER BONE MARROW TRANS-
PLANTATION IN PREMATURE MONOZYGOTIC TWINS WITH FAMILIAL
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (FLH)
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Introduction: Familial hemophagocytic lymphohistiocytosis
is a rare histiocytic disorder with hepatosplenomegaly, fever,
infections and hemophagocytosis visible in biopsies of hemato-
poietic and lymphoid tissue. Hematopoietic stem cell transplan-
tation is the only curative option. Bone marrow transplant
recipients with FLH are at an increased risk for VOD as busul-
fan-based conditioning regimens add to liver toxicity. Here, we
report two female, premature, identical twins with FLH and
severe VOD following allogeneic BMT. Case reports. After
diagnosis of FLH in the 2 months-old twins in spring 2006, the
children achieved complete remission using protocol HLH-
2004 (dexamethasone, etoposide, CsA) after 3 months. The girls
received an unrelated matched marrow transplant from the same
donor. The preparative regimen consisted of i.v. busulfan
16mg/kg BW, cyclophosphamide 200mg/kg BW and ATG
40mg/kg BW; GvHD prophylaxis was CsA and short course
MTX. Twin A was transplanted two weeks prior to her sister.
On day 9, she developed VOD associated with oliguria, renal
and respiratory insufficiency necessitating mechanical ventila-
tion. Further complications were disseminated intravascular co-
agulation (DIC) and potentially CsA-induced thrombocytope-
nic purpura requiring support with cellular and plasmatic blood
products. Defibrotide and heparin were started with the onset of
VOD and DIC. On day 49, her bilirubin varies between 20
and 30mg/dl, but otherwise she displays improved hepatic pa-
rameters, is breathing spontaneously with minimal, additional
oxygen supply, has a sufficient urine output and no infections or
GvHD under steroids and MMF. In twin B, the prophylactic use
of defibrotide could not prevent VOD being diagnosed on day
13. However, she was not as severely affected as her sister
without the need for mechanical ventilation. In other respects,
she experienced the same complications. On day 35, her bil-
irubin varies between 15 and 25mg/dl, but she demonstrates a
gradual improvement of hepatic function, her respiratory sys-
tem is not impaired, the renal function slightly reduced under
CsA. Both girls engrafted rapidly and exhibit full donor cell
chimerism. Discussion. Significant liver involvement in FLH
patients poses a considerable risk for developing VOD. The use
of defibrotide could not prevent, but may have mitigated the
severity of VOD in the second child. Children with FLH and a
high risk for VOD may be considered for reduced intensity
conditioning regimens.
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